Fluconazole resistance of Candida krusei

Boll Ist Sieroter Milan. 1991;70(1-2):527-9.

Abstract

We present a case of young male treated for a recurrence of Acute Non Lymphoid Leukemia who presented a colonization by C. krusei during prophylaxis with Fluconazole. The fever episode, which he developed while neutropenic, was resolved with the addition of Amphotericin B after the failure of empiric antibiotic therapy. No isolation was performed in blood cultures. A second cycle of antiblastic chemotherapy was needed because of the resistance shown to the first. Despite the prophylaxis with Fluconazole a stream of C. krusei grew in all the blood cultures collected while febrile. Amphotericin B administered did not control the fungemia. We discuss the resistance of C. krusei to Fluconazole.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amphotericin B / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Candida / drug effects*
  • Candidiasis / drug therapy
  • Candidiasis / etiology
  • Candidiasis / microbiology*
  • Candidiasis / prevention & control
  • Candidiasis, Oral / drug therapy
  • Candidiasis, Oral / etiology
  • Candidiasis, Oral / microbiology
  • Cytarabine / administration & dosage
  • Drug Resistance, Microbial
  • Drug Therapy, Combination / therapeutic use
  • Fatal Outcome
  • Fluconazole / pharmacology*
  • Fluconazole / therapeutic use
  • Flucytosine / therapeutic use
  • Fungemia / drug therapy
  • Fungemia / etiology
  • Fungemia / microbiology*
  • Humans
  • Leukemia, Myeloid, Acute / complications
  • Leukemia, Myeloid, Acute / drug therapy
  • Male
  • Mitoxantrone / administration & dosage

Substances

  • Cytarabine
  • Amphotericin B
  • Fluconazole
  • Mitoxantrone
  • Flucytosine